Market Highlights: Bitcoin Surge Powers Crypto Stocks While Moderna (MRNA) Resolves Patent Dispute
TLDR
Bitcoin surged approximately 5% to reach $71,418, propelling cryptocurrency stocks higher including Strategy (+8%), Coinbase (+7%), and Riot Platforms (+4%)
Moderna resolved a patent dispute worth $950M related to its COVID-19 vaccine technology, below market concerns
Ross Stores exceeded fourth-quarter projections and upgraded its outlook, sending shares up as much as 7.5%
GitLab declined roughly 9% even after surpassing Q4 expectations, due to disappointing full-year revenue projections
Horizon Technology Finance tumbled 10% following total investment income of $20.7M versus the $23.9M consensus
Wednesday witnessed a significant Bitcoin recovery, with the cryptocurrency advancing approximately 5% to settle near $71,418. This upward momentum created a ripple effect throughout crypto-linked equities.
Strategy climbed 8%, while Coinbase experienced gains of roughly 7%, and MARA Holdings advanced 7%. Meanwhile, Riot Platforms, Robinhood Markets, Galaxy Digital, and Hut 8 each registered increases ranging from 4% to 5%. Circle Internet Group posted a 6% advance.
Coinbase Global, Inc., COIN
The cryptocurrency market rebound followed a recent downturn connected to escalating geopolitical tensions in the Middle East. Market participants appeared to regain appetite for risk assets as conditions began normalizing.
Precious metal mining companies also experienced gains Wednesday. Newmont advanced 2.8% while Freeport-McMoRan increased 1.9%, as Middle Eastern instability drove certain investors toward traditional safe-haven commodities like gold.
Moderna Resolves Patent Litigation for $950M
Moderna finalized a $950 million agreement with Arbutus Biopharma and Genevant Sciences. The litigation centered on intellectual property claims related to its coronavirus and RSV vaccine platforms.
Investors welcomed the settlement as favorable news, given expectations for a substantially higher payout. Moderna’s coronavirus vaccine has produced revenue ranging from $45 billion to $50 billion.
The company will make the payment during the third quarter while recording it as a first-quarter expense. Following this settlement, Moderna anticipates finishing the year with cash reserves between $4.5 billion and $5 billion.
Moderna plans to continue its appeal with the U.S. Federal Circuit. A positive outcome could eliminate any further financial obligation, while an unfavorable verdict might require an additional payment of up to $1.3 billion within 90 days.
Ross Stores delivered impressive performance, climbing as high as 7.5% during premarket hours. The discount retailer surpassed fourth-quarter projections and provided first-quarter guidance significantly exceeding Street estimates.
For the first quarter, Ross anticipates comparable store sales growth between 7% and 8%, compared to analyst projections of approximately 3.7%. The retailer also announced a 10% dividend increase.
GitLab and Horizon Decline on Disappointing Forecasts
GitLab retreated between 8.5% and 9% despite delivering better-than-expected fourth-quarter results. The software company’s annual revenue forecast of $1.099 billion to $1.118 billion fell short of the $1.13 billion consensus estimate.
Chief Executive Bill Staples acknowledged dissatisfaction with the revenue outlook and presented a five-point strategy to accelerate expansion.
Horizon Technology Finance plunged 10% after disclosing total investment income of $20.7 million, missing the $23.9 million forecast. The company’s net asset value per share also declined slightly during the period.
CrowdStrike inched up 1.1% following fourth-quarter results that exceeded both earnings and revenue projections. Box rallied 6.2% after outperforming Wall Street estimates and providing encouraging guidance for the ongoing quarter.
Broadcom gained 1% in anticipation of its fiscal first-quarter earnings release scheduled after market close, with industry watchers projecting semiconductor revenue growth of 51% on a year-over-year basis.
